Ampicillin Resistance of Shigella sonnei
- 1 October 1974
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 6 (4) , 418-421
- https://doi.org/10.1128/aac.6.4.418
Abstract
The ampicillin resistance of clinical isolates of Shigella sonnei is due to beta-lactamase production. Two kinds of resistance are found: low level, nontransmissible; and high level, tranmissible. The nontransmissible type of resistance results from a chromosomal mutation which increases the production of a beta-lactamase that hydrolyses cephalosporins relatively rapidly and gives cephalothin resistance. The transmissible type of resistance is due to an R factor mediating the synthesis of a different beta-lactamase that does not significantly hydrolyze cephalosporins or confer cephalothin resistance. One clinical isolate is shown to possess simultaneously both these mechanisms of ampicillin resistance.Keywords
This publication has 8 references indexed in Scilit:
- R Factors from Proteus rettgeriJournal of General Microbiology, 1972
- The purification and properties of the β-lactamase specified by the resistance factor R-1818 in Escherichia coli and Proteus mirabilisBiochemical Journal, 1971
- ANTIBIOTIC RESISTANCE OF SHIGELLA SONNEIThe Lancet, 1970
- R-factor Gene Expression in Gram-negative BacteriaJournal of General Microbiology, 1969
- Further studies on the antibiotic resistance ofShigella sonnei: I. Transferable antibiotic resistanceEpidemiology and Infection, 1968
- Resistance ofEscherichia colito penicillins: IV. Genetic study of mutants resistant to D, L-ampicillin concentrations of 100 μg/ml.Genetics Research, 1968
- The ampicillin resistance of Shigella sonnei: its epidemiological value.1966
- Penicillinase and Ampicillin Resistance in a Strain of Escherichia coliJournal of General Microbiology, 1963